Human-like antibodies neutralizing Western equine encephalitis virus

mAbs

Volumn 6, Issue 3, 2014, Pages 717-726

  Hülseweh, Birgit ^a   Rülker, Torsten ^b   Pelat, Thibaut ^c   Langermann, Claudia ^a   Frenzel, Andrè ^b   Schirrmann, Thomas ^b   Dub̈el, Stefan ^b   Thullier, Philippe ^c   Hust, Michael ^b  

^a Wehrwissenschaftliches Institut für Schutztechnologien   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^c INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

Alphavirus; Immune antibody library; NHP antibodies; Passive vaccine; Phage display; ScFv; ScFv Fc; Western equine encephalitis virus (WEEV)

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TOR68 2C3; TOR68 2E9; TOR68 3G2; TOR69 3A2; UNCLASSIFIED DRUG; VIRUS VACCINE; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CHO CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACACA; NONHUMAN; POST EXPOSURE PROPHYLAXIS; VIRUS PARTICLE; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; ANIMAL; CROSS REACTION; ENCEPHALOMYELITIS, EQUINE; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; MACACA FASCICULARIS; MALE; MOLECULAR CLONING; PASSIVE IMMUNIZATION; PATHOGENICITY; PEPTIDE LIBRARY; WESTERN EQUINE ENCEPHALITIS VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CLONING, MOLECULAR; CROSS REACTIONS; ENCEPHALITIS VIRUS, WESTERN EQUINE; ENCEPHALOMYELITIS, EQUINE; HUMANS; IMMUNIZATION; IMMUNIZATION, PASSIVE; MACACA FASCICULARIS; MALE; PEPTIDE LIBRARY; POST-EXPOSURE PROPHYLAXIS; SINGLE-CHAIN ANTIBODIES;

EID: 84899706736     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.28170     Document Type: Article

References (77)

1. Hahn CS, Lustig S, Strauss EG, Strauss JH. Western equine encephalitis virus is a recombinant virus. Proc Natl Acad Sci U S A 1988; 85:5997-6001; PMID:3413072; http://dx.doi.org/10.1073/pnas.85.16.5997
2. Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, Weaver SC. Evolutionary relationships and systematics of the alphaviruses. J Virol 2001; 75:10118-31; PMID:11581380; http://dx.doi.org/10.1128/JVI.75.21.10118- 10131.2001
3. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 1994; 58:491-562; PMID:7968923
4. Sherman MB, Weaver SC. Structure of the recombinant alphavirus Western equine encephalitis virus revealed by cryoelectron microscopy. J Virol 2010; 84:9775-82; PMID:20631130; http://dx.doi.org/10.1128/JVI.00876-10
5. Giltner LT, Shahan MS. The immunological relationship of eastern and western strains of equine encephalomyelitis virus. Science 1933; 78:587-8; PMID:17801697; http://dx.doi.org/10.1126/science.78.2034.587-a
6. King LS. Studies on eastern equine encephalomyelitis?: III. intraocular infection with fixed virus in the guinea pig. J Exp Med 1939; 69:691-704; PMID:19870871; http://dx.doi.org/10.1084/jem.69.5.691
7. Kubes V, Ríos FA. The causative agent of infectious equine encephalomyelitis in venezuela. Science 1939; 90:20-1; PMID:17818578; http://dx.doi.org/10.1126/science.90.2323.20
8. Weaver SC, Ferro C, Barrera R, Boshell J, Navarro J-C. Venezuelan equine encephalitis. Annu Rev Entomol 2004; 49:141-74; PMID:14651460; http://dx.doi.org/10.1146/annurev.ento.49.061802.123422
9. Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol 2010; 140:281-6; PMID:19775836; http://dx.doi.org/10.1016/j.vetmic.2009.08.023
10. Oviedo MVN, Romoser WS, James CB, Mahmood F, Reisen WK. Infection dynamics of western equine encephalomyelitis virus (Togaviridae: Alphavirus) in four strains of Culex tarsalis (Diptera: Culicidae): an immunocytochemical study. Res Rep Trop Med 2011; 2011:65-77; PMID:22629118
11. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994; 7:89-116; PMID:8118792
12. Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997; 336:1867-74; PMID:9197215; http://dx.doi.org/10.1056/NEJM199706263362604
13. Feemster RF. Outbreak of Encephalitis in Man Due to the Eastern Virus of Equine Encephalomyelitis. Am J Public Health Nations Health 1938; 28:1403-10; PMID:18014957; http://dx.doi.org/10.2105/ AJPH.28.12.1403
14. Leitenberg M. Biological weapons in the twentieth century: a review and analysis. Crit Rev Microbiol 2001; 27:267-320; PMID:11791799; http://dx.doi.org/10.1080/20014091096774
15. Letson GW, Bailey RE, Pearson J, Tsai TF. Eastern equine encephalitis (EEE): a description of the 1989 outbreak, recent epidemiologic trends, and the association of rainfall with EEE occurrence. Am J Trop Med Hyg 1993; 49:677-85; PMID:8279635
16. Mossel EC, Ledermann JP, Phillips AT, Borland EM, Powers AM, Olson KE. Molecular determinants of mouse neurovirulence and mosquito infection for Western equine encephalitis virus. PLoS One 2013; 8:e60427; PMID:23544138; http://dx.doi.org/10.1371/journal.pone.0060427
17. Rivas F, Diaz LA, Cardenas VM, Daza E, Bruzon L, Alcala A, De la Hoz O, Caceres FM, Aristizabal G, Martinez JW, et al. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis 1997; 175:828-32; PMID:9086137; http://dx.doi.org/10.1086/513978
18. Rozdilsky B, Robertson HE, Chorney J. Western encephalitis: report of eight fatal cases. Saskatchewan epidemic, 1965. Can Med Assoc J 1968; 98:79-86; PMID:5688720
19. Sanchez JL, Takafuji ET, Lednar WM, LeDuc JW, Macasaet FF, Mangiafico JA, Rosato RR, Driggers DP, Haecker JC. Venezuelan equine encephalomyelitis: report of an outbreak associated with jungle exposure. Mil Med 1984; 149:618-21; PMID:6438552
20. Sudia WD, McLean RG, Newhouse VF, Johnston JG, Miller DL, Trevino H, Bowen GS, Sather G. Epidemic Venezuelan equine encephalitis in North America in 1971: vertebrate field studies. Am J Epidemiol 1975; 101:36-50; PMID:1119481
21. Swayze RD, Bhogal HS, Barabé ND, McLaws LJ, Wu JQH. Envelope protein E1 as vaccine target for western equine encephalitis virus. Vaccine 2011; 29:813-20; PMID:21084062; http://dx.doi.org/10.1016/j.vaccine.2010.11.009
22. Delfraro A, Burgueño A, Morel N, González G, García A, Morelli J, Pérez W, Chiparelli H, Arbiza J. Fatal human case of Western equine encephalitis, Uruguay. Emerg Infect Dis 2011; 17:952-4; PMID:21529429; http://dx.doi.org/10.3201/eid1705.101068
23. Reeves WC, Hutson GA, Bellamy RE, Scrivani RP. Chronic latent infections of birds with Western equine encephalomyelitis virus. Proc Soc Exp Biol Med 1958; 97:733-6; PMID:13554464; http://dx.doi.org/10.3181/00379727-97-23862
24. Logue CH, Bosio CF, Welte T, Keene KM, Ledermann JP, Phillips A, Sheahan BJ, Pierro DJ, Marlenee N, Brault AC, et al. Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model. J Gen Virol 2009; 90:1848-58; PMID:19403754; http://dx.doi.org/10.1099/vir.0.008656-0
25. Nagata LP, Hu W-G, Parker M, Chau D, Rayner GA, Schmaltz FL, Wong JP. Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. J Gen Virol 2006; 87:2353-61; PMID:16847131; http://dx.doi.org/10.1099/vir.0.81815-0
26. Phillpotts RJ. Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III. Virus Res 2006; 120:107-12; PMID:16621103; http://dx.doi.org/10.1016/j.virusres.2006.02.003
27. Reed DS, Larsen T, Sullivan LJ, Lind CM, Lackemeyer MG, Pratt WD, Parker MD. Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. J Infect Dis 2005; 192:1173-82; PMID:16136459; http://dx.doi.org/10.1086/444397
28. Hawley RJ, Eitzen EM Jr. Biological weapons - a primer for microbiologists. Annu Rev Microbiol 2001; 55:235-53; PMID:11544355; http://dx.doi.org/10.1146/annurev.micro.55.1.235
29. Sidwell RW, Smee DF. Viruses of the Bunya - and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res 2003; 57:101-11; PMID:12615306; http://dx.doi.org/10.1016/S0166-3542(02)00203-6
30. Nagata LP, Wong JP, Hu W-G, Wu JQ. Vaccines and therapeutics for the encephalitic alphaviruses. Future Virol 2013; 8:661-74; http://dx.doi.org/10. 2217/fvl.13.42
31. Atasheva S, Wang E, Adams AP, Plante KS, Ni S, Taylor K, Miller ME, Frolov I, Weaver SC. Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus. Vaccine 2009; 27:4309-19; PMID:19446595; http://dx.doi.org/10.1016/j.vaccine.2009.05.011
32. Barabé ND, Rayner GA, Christopher ME, Nagata LP, Wu JQH. Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus. Vaccine 2007; 25:6271-6; PMID:17630056; http://dx.doi.org/10.1016/ j.vaccine.2007.05.054
33. Wu JQH, Barabé ND, Chau D, Wong C, Rayner GR, Hu W-G, Nagata LP. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine. Vaccine 2007; 25:4368-75; PMID:17467858; http://dx.doi.org/10.1016/j.vaccine. 2007.03.042
34. Nagata LP, Hu W-G, Masri SA, Rayner GA, Schmaltz FL, Das D, Wu J, Long MC, Chan C, Proll D, et al. Efficacy of DNA vaccination against western equine encephalitis virus infection. Vaccine 2005; 23:2280-3; PMID:15755611; http://dx.doi.org/10.1016/j.vaccine.2005.01.032
35. Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine. Vaccine 2009; 27:4152-60; PMID:19406186; http://dx.doi.org/10. 1016/j.vaccine.2009.04.049
36. Logue CH, Phillips AT, Mossel EC, Ledermann JP, Welte T, Dow SW, Olson KE, Powers AM. Treatment with cationic liposome-DNA complexes (CLDCs) protects mice from lethal Western equine encephalitis virus (WEEV) challenge. Antiviral Res 2010; 87:195-203; PMID:20452378; http://dx.doi.org/10.1016/j.antiviral.2010. 04.013
37. Phillips AT, Stauft CB, Aboellail TA, Toth AM, Jarvis DL, Powers AM, Olson KE. Bioluminescent imaging and histopathologic characterization of WEEV neuroinvasion in outbred CD-1 mice. PLoS One 2013; 8:e53462; PMID:23301074; http://dx.doi.org/10.1371/journal.pone.0053462
38. Das D, Kriangkum J, Nagata LP, Fulton RE, Suresh MR. Development of a biotin mimic tagged ScFv antibody against western equine encephalitis virus: bacterial expression and refolding. J Virol Methods 2004; 117:169-77; PMID:15041214; http://dx.doi.org/10.1016/j.jviromet.2004.01.008
39. Xu B, Kriangkum J, Nagata LP, Fulton RE, Suresh MR. A single chain Fv specific against Western equine encephalitis virus. Hybridoma 1999; 18:315-23; PMID:10571261; http://dx.doi.org/10.1089/hyb.1999.18.315
40. Long MC, Jager S, Mah DC, Jebailey L, Mah MA, Masri SA, Nagata LP. Construction and characterization of a novel recombinant single-chain variable fragment antibody against Western equine encephalitis virus. Hybridoma 2000; 19:1-13; PMID:10768836; http://dx.doi.org/10.1089/027245700315743
41. Avril A, Froude JW, Mathieu J, Pelat T, Thullier P. Isolation of antibodies from non-human primates for clinical use. Curr Drug Discov Technol 2014; 11:20- 7; PMID:23410051; http://dx.doi.org/10.2174/15701638113109990030
42. Pelat T, Hust M, Thullier P. Obtention and engineering of non-human primate (NHP) antibodies for therapeutics. Mini Rev Med Chem 2009; 9:1633-8; PMID:20105119; http://dx.doi.org/10.2174/138955709791012283
43. Duggan JM, Coates DM, Ulaeto DO. Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources. Viral Immunol 2001; 14:263-73; PMID:11572636; http://dx.doi.org/10.1089/088282401753266774
44. Hunt AR, Frederickson S, Maruyama T, Roehrig JT, Blair CD. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity. PLoS Negl Trop Dis 2010; 4:e739; PMID:20644615; http://dx.doi.org/10.1371/journal.pntd.0000739
45. Kirsch MI, Hülseweh B, Nacke C, Rülker T, Schirrmann T, Marschall H-J, Hust M, Dübel S. Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol 2008; 8:66; PMID:18764933; http://dx.doi.org/10.1186/1472-6750-8-66
46. Rülker T, Voß L, Thullier P, O' Brien LM, Pelat T, Perkins SD, Langermann C, Schirrmann T, Dübel S, Marschall H-J, et al. Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo. PLoS One 2012; 7:e37242; PMID:22666347; http://dx.doi.org/10.1371/journal.pone.0037242
47. Hust M, Meyer T, Voedisch B, Rülker T, Thie H, El-Ghezal A, Kirsch MI, Schütte M, Helmsing S, Meier D, et al. A human scFv antibody generation pipeline for proteome research. J Biotechnol 2011; 152:159-70; PMID:20883731; http://dx.doi.org/10.1016/j.jbiotec.2010.09.945
48. Rondot S, Koch J, Breitling F, Dübel S. A helper phage to improve single-chain antibody presentation in phage display. Nat Biotechnol 2001; 19:75-8; PMID:11135557; http://dx.doi.org/10.1038/83567
49. Soltes G, Hust M, Ng KKY, Bansal A, Field J, Stewart DIH, Dübel S, Cha S, Wiersma EJ. On the influence of vector design on antibody phage display. J Biotechnol 2007; 127:626-37; PMID:16996161; http://dx.doi.org/10.1016/j. jbiotec.2006.08.015
50. Jäger V, Büssow K, Wagner A, Weber S, Hust M, Frenzel A, Schirrmann T. High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol 2013; 13:52; PMID:23802841; http://dx.doi.org/10.1186/1472-6750-13-52
51. Greiser-Wilke I, Moenning V, Kaaden OR, Figueiredo LT. Most alphaviruses share a conserved epitopic region on their nucleocapsid protein. J Gen Virol 1989; 70:743-8; PMID:2471798; http://dx.doi.org/10.1099/0022-1317-70-3-743
52. Wu JQH, Barabé ND, Huang Y-M, Rayner GA, Christopher ME, Schmaltz FL. Pre - and postexposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha. Virology 2007; 369:206-13; PMID:17761207; http://dx.doi.org/10.1016/j.virol. 2007.07.024
53. Sabin AB. Quantitative studies on prophylactic effectiveness of western equine encephalitis antiserum in mice. Proc Soc Exp Biol Med 1951; 78:655-8; PMID:14911984; http://dx.doi.org/10.3181/00379727-78-19172
54. Reichert E, Clase A, Bacetty A, Larsen J. Alphavirus antiviral drug development: scientific gap analysis and prospective research areas. Biosecur Bioterror 2009; 7:413-27; PMID:20028250; http://dx.doi.org/10.1089/bsp.2009.0032
55. Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RTP, Bertin-Maghit S, Ng LFP, Abastado J-P, Desprès P, et al. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J Immunol 2011; 186:3258-64; PMID:21278338; http://dx.doi.org/10.4049/ jimmunol.1003139
56. Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I, Akahata W, Nabel GJ, Richter MKS, et al. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog 2013; 9:e1003312; PMID:23637602; http://dx.doi.org/10.1371/journal.ppat.1003312
57. Roehrig JT, Day JW, Kinney RM. Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC- 83) using monoclonal antibodies. Virology 1982; 118:269-78; PMID:6178209; http://dx.doi.org/10.1016/0042-6822(82)90346-4
58. Goodchild SA, O'Brien LM, Steven J, Muller MR, Lanning OJ, Logue CH, D'Elia RV, Phillpotts RJ, Perkins SD. A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus. Antiviral Res 2011; 90:1-8; PMID:21310183; http://dx.doi.org/10.1016/j.antiviral.2011.01.010
59. Hunt AR, Frederickson S, Hinkel C, Bowdish KS, Roehrig JT. A humanized murine monoclonal antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus. J Gen Virol 2006; 87:2467-76; PMID:16894184; http://dx.doi.org/10.1099/vir.0.81925-0
60. Hu W-G, Phelps AL, Jager S, Chau D, Hu CC, O'Brien LM, Perkins SD, Gates AJ, Phillpotts RJ, Nagata LP. A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus. Vaccine 2010; 28:5558-64; PMID:20600509; http://dx.doi.org/10.1016/j.vaccine.2010.06.038
61. O'Brien LM, Underwood-Fowler CD, Goodchild SA, Phelps AL, Phillpotts RJ. Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains. Virol J 2009; 6:206; PMID:19925641; http://dx.doi.org/10.1186/1743-422X-6-206
62. Pelat T, Hust M, Laffly E, Condemine F, Bottex C, Vidal D, Lefranc M-P, Dübel S, Thullier P. Highaffinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother 2007; 51:2758-64; PMID:17517846; http://dx.doi.org/10.1128/AAC. 01528-06
63. Chahboun S, Hust M, Liu Y, Pelat T, Miethe S, Helmsing S, Jones RG, Sesardic D, Thullier P. Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin. BMC Biotechnol 2011; 11:113; PMID:22111995; http://dx.doi.org/10.1186/1472-6750-11-113
64. Pelat T, Hust M, Hale M, Lefranc M-P, Dübel S, Thullier P. Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol 2009; 9:60; PMID:19563687; http://dx.doi.org/10.1186/ 1472-6750-9-60
65. Laffly E, Danjou L, Condemine F, Vidal D, Drouet E, Lefranc M-P, Bottex C, Thullier P. Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Antimicrob Agents Chemother 2005; 49:3414-20; PMID:16048955; http://dx.doi.org/10.1128/AAC.49.8.3414-3420.2005
66. Pelat T, Bedouelle H, Rees AR, Crennell SJ, Lefranc M-P, Thullier P. Germline humanization of a nonhuman primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J Mol Biol 2008; 384:1400-7; PMID:18976662; http://dx.doi.org/10.1016/j.jmb.2008.10.033
67. USDA Animal Welfare Act (AWA). 7 U.S.C. 2131 et seq., as amended and Health Research Extension Act of 1985 ("'Animals in Research'"). 1985.
68. National Research Council. Guide for the Care and Use of Laboratory Animals. Eighth Edition. Washington: The National Academies Press; 2011.
69. Huelseweh B, Ehricht R, Marschall H-J. A simple and rapid protein array based method for the simultaneous detection of biowarfare agents. Proteomics 2006; 6:2972-81; PMID:16622830; http://dx.doi.org/10.1002/pmic.200500721
70. Sagripanti J-L, Hülseweh B, Grote G, Voss L, Böhling K, Marschall H-J. Microbial inactivation for safe and rapid diagnostics of infectious samples. Appl Environ Microbiol 2011; 77:7289-95; PMID:21856830; http://dx.doi.org/10.1128/AEM.05553-11
71. Hamilton MA, Russo RC, Thurston RV. Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays. Enviromental Sci Technol 1977; 11:714-9; http://dx.doi.org/10.1021/es60130a004
72. Schütte M, Thullier P, Pelat T, Wezler X, Rosenstock P, Hinz D, Kirsch MI, Hasenberg M, Frank R, Schirrmann T, et al. Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One 2009; 4:e6625; PMID:19675673; http://dx.doi.org/10.1371/journal.pone.0006625
73. Frenzel A, Kügler J, Wilke S, Schirrmann T, Hust M. Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol 2014; 1060:215-43; PMID:24037844; http://dx.doi.org/10.1007/ 978-1-62703-586-6-12
74. Sambrook J, Russell D. Molecular cloning: a laboratory manual. 3nd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
75. Henchal EA, Gentry MK, McCown JM, Brandt WE. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 1982; 31:830-6; PMID:6285749
76. Greiser-Wilke IM, Moennig V, Kaaden OR, Shope RE. Detection of alphaviruses in a genus-specific antigen capture enzyme immunoassay using monoclonal antibodies. J Clin Microbiol 1991; 29:131-7; PMID:1847149
77. Jensen MH. Detection of antibodies against hog cholera virus and bovine viral diarrhea virus in porcine serum. A comparative examination using CF, PLA and NPLA assays. Acta Vet Scand 1981; 22:85-98; PMID:6266240